Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Comparative Confusion: What Does FDA Intend For Opioid Comparative Efficacy Data?
Jul 18 2019
•
By
Derrick Gingery
How will FDA react if an opioid application does not include comparative efficacy and safety data? • Source: Shutterstock
More from Approval Standards
More from Pathways & Standards